Cancer Research UK
The United Kingdom's largest independent cancer research charity, funding research, influencing policy, and providing cancer information and support.
Last updated November 4, 2026
AI crawler reads
3requests
1companies- Anthropic3
- Profile
- 2
- Controversies
- 0
- JSON · MD
- 0
- First read
- Nov 4, 2026
- Latest read
- Nov 4, 2026
From this site's server log
Overview
Cancer Research UK is a United Kingdom-based cancer research and public-health charity. It funds laboratory, clinical, population and prevention research; supports scientists, research infrastructure and clinical trials; publishes information for people affected by cancer; campaigns for policies intended to reduce cancer incidence and improve outcomes; and raises money through public donations, community events, partnerships, legacies and a large network of charity shops. Its work covers the full research and cancer-control pathway, from understanding cancer biology and identifying risk factors to developing diagnostics, treatments and approaches to survivorship. The modern organisation was created in 2002 through the merger of the Cancer Research Campaign and the Imperial Cancer Research Fund. Those predecessor organisations had much longer histories and had supported important British cancer research, fundraising and public-awareness work before the merger. Cancer Research UK therefore operates as a successor organisation rather than as a charity founded from nothing in 2002. The merger created a single national fundraising and research body with a broad scientific portfolio and a prominent public-facing identity. The charity is independent of government and is not a commercial healthcare provider. It distributes charitable income through research grants, fellowships, infrastructure support and strategic programmes, while also collaborating with universities, hospitals, research institutes, government bodies and international scientific partners. Its policy activity includes advocacy on tobacco control, cancer prevention, screening, early diagnosis, access to treatment and research funding. Its public information services explain cancer symptoms, risk factors, diagnosis, treatment and support in language intended for patients, families and the wider public. Cancer Research UK is also a major consumer-facing fundraising brand. Long-running activities include Race for Life, which began under the Cancer Research Campaign before the 2002 merger, as well as sponsored challenges, local events, regular giving, appeals and legacy fundraising. The organisation operates branded shops that sell donated and new goods, helping convert community participation and donated merchandise into unrestricted charitable income. Partnerships with broadcasters, retailers, sports organisations and other businesses extend its reach, although campaigns and commercial relationships are governed by the charity's fundraising and brand policies. The organisation's public positioning combines scientific credibility with mass participation. Its message is generally framed around accelerating progress against cancer and improving survival and quality of life, rather than promising a single cure. Cancer Research UK has remained active as cancer research, treatment and public policy have changed, including through work on precision medicine, prevention, early detection, clinical trials, inequalities and the effects of the COVID-19 pandemic on diagnosis and research. It is a charity, not a listed company, and therefore has no public stock ticker. Its chief executive is Michelle Mitchell, who has led the organisation since 2018.
History
Cancer Research UK's history is rooted in several earlier British cancer organisations. The two immediate predecessors were the Cancer Research Campaign and the Imperial Cancer Research Fund. Both raised charitable money for cancer science and supported research institutions, laboratories, clinicians and public education over many decades. Their activities contributed to the development of modern cancer biology, epidemiology, prevention and treatment research in the United Kingdom. The predecessor organisations also established public fundraising traditions that later became associated with the Cancer Research UK name. In 2002, the Cancer Research Campaign and the Imperial Cancer Research Fund merged to create Cancer Research UK. The merger brought together research portfolios, fundraising operations, policy work and public information activity under one national charity. It also created a stronger single brand for communicating with donors, volunteers, patients, researchers and policymakers. The new organisation inherited research assets and programmes from both predecessor bodies, so 2002 is best understood as the formation date of the current charity rather than the beginning of its institutional history. After the merger, Cancer Research UK expanded its role beyond grant-making. It developed a national public-facing programme covering cancer awareness, prevention, early diagnosis and patient information, while continuing to fund research at universities, hospitals and specialist institutes. The charity also supported clinical and translational research intended to move discoveries from laboratories into tests, medicines, procedures and improved care. Its policy work increasingly addressed population-level causes of cancer, including tobacco, alcohol, obesity, ultraviolet exposure and infectious causes, alongside screening and health inequalities. Fundraising became an important part of the organisation's public identity. Race for Life, launched by the Cancer Research Campaign in 1994, continued under the Cancer Research UK brand after the merger and became one of the UK's best-known charity participation events. Sponsored challenges, regular giving, legacy donations, community events and charity shops broadened the income base. The organisation also formed high-profile media and commercial partnerships, including the UK Stand Up To Cancer campaign with Channel 4. During the 2010s, Cancer Research UK placed increasing emphasis on earlier diagnosis, prevention, precision medicine, clinical trials and the use of large-scale data. It continued to combine direct research funding with campaigning for government action and better access to cancer services. In 2018, Michelle Mitchell became chief executive. Her tenure included the pandemic period, when the charity faced reduced fundraising, interruptions to research and concerns about delayed diagnosis and treatment. Cancer Research UK responded through public information, policy advocacy and efforts to protect research capacity. Today, Cancer Research UK remains an independent UK charity with a broad remit: funding discovery and applied research, supporting researchers and infrastructure, informing the public, campaigning on cancer policy, and generating public participation through events and retail. Its operating model depends on donations and other charitable income rather than commercial sales or listed-company capital markets. The organisation presents progress against cancer as a cumulative scientific and health-system effort, with continuing challenges around prevention, unequal outcomes, late diagnosis, treatment access and sustainable research funding.
- 2020
Pandemic disruption affects cancer research and care
[5]The COVID-19 crisis disrupted fundraising, research activity, cancer diagnosis and treatment, prompting Cancer Research UK to campaign for protection of cancer services and research.
- 2018
Michelle Mitchell becomes chief executive
[2]Michelle Mitchell took over as Cancer Research UK's chief executive.
- 2012
Stand Up To Cancer launches in the UK
[4]Cancer Research UK partnered with Channel 4 to bring the Stand Up To Cancer fundraising campaign to UK audiences.
- 2002
Cancer Research UK is formed
[1]The Cancer Research Campaign and Imperial Cancer Research Fund merged to form Cancer Research UK.
- 1994
Race for Life begins
[3]The Cancer Research Campaign introduced Race for Life, which later became a major Cancer Research UK fundraising event after the 2002 merger.
Products and positioning
A science-led, public-facing cancer charity combining research funding with prevention, policy advocacy, information, support and mass-participation fundraising.
Charitable research programme · 2002
Research funding
Cancer Research UK funds discovery science, prevention research, early-detection work, clinical research, translational programmes, fellowships and research infrastructure. Grants support researchers and institutions across the UK and are intended to improve understanding of cancer and convert scientific findings into better prevention, diagnosis and treatment.
Public information service · 2002
Cancer information and support
The charity provides online information about cancer symptoms, risk factors, prevention, diagnosis, treatment, side effects and living with cancer. Its information service is designed for patients, relatives, carers and the general public, and complements rather than replaces advice from qualified healthcare professionals.
Fundraising event · 1994
Race for Life
Race for Life is a mass-participation fundraising programme featuring runs and related events. It began under the Cancer Research Campaign in 1994 and continued under Cancer Research UK after the merger. Participants raise donations while taking part in events supporting cancer research.
Charity retail · 2002
Charity shops
Cancer Research UK charity shops sell donated clothing, books, household goods and other merchandise, with proceeds supporting the charity's work. The shops also provide a visible local presence and encourage reuse through second-hand retail.
Marketing campaigns
- 2012Stand Up To Cancer UK
United Kingdom
Cancer Research UK worked with Channel 4 to adapt the Stand Up To Cancer fundraising format for the UK, combining broadcast programming, celebrity participation and public donations.
Outcome. The partnership created a recurring high-profile fundraising platform for cancer research.
- 1994Race for Life
United Kingdom
The Cancer Research Campaign created Race for Life as a women-focused mass-participation fundraising event. The programme continued as a Cancer Research UK flagship activity after the 2002 merger and developed into a broad portfolio of running and participation events.
Outcome. It became one of the charity's most recognisable public fundraising brands.
Brand decisions
2020
Protect cancer research and services during COVID-19 disruptionStrategyBackground
The pandemic reduced charitable fundraising and disrupted laboratory research, cancer diagnosis and treatment.
Action taken
Cancer Research UK used public communications and policy advocacy to highlight the effects of the disruption and call for protection of cancer research and cancer services.
Aftermath
The pandemic became a major organisational and sector challenge, with continued emphasis on restoring diagnosis, treatment and research capacity.
2002
Merge two major cancer charitiesM&ABackground
The Cancer Research Campaign and the Imperial Cancer Research Fund were separate organisations with overlapping cancer research and fundraising missions.
Action taken
They combined their operations and assets to establish Cancer Research UK.
Aftermath
The merger created a single national cancer research charity and unified the predecessor organisations' public fundraising and research activities.
Recent events
Cancer Research UK and ALBORADA Trust announce fellowship partnership[6]
Cancer Research UK announced a £9 million donation from the ALBORADA Trust and said it would match the donation, creating £18 million in total funding for 12 fellowships. The Trust described the arrangement as a new long-term partnership with Cancer Research UK.
Reported
Tesco works with health charities to promote flu vaccination[7]
Tesco said it is working with the British Heart Foundation, Diabetes UK and Cancer Research UK to promote the importance of flu vaccination.
Reported
Cancer Research UK and Teon collaborate on TT-702 development[8]
Cancer Research UK signed a collaboration agreement with Teon Therapeutics to advance early clinical development of Teon's cancer drug TT-702. Cancer Research UK will sponsor the first-in-human Phase I/II clinical development.
Reported
Cancer Research UK plans job cuts[9]
Cancer Research UK said it would make significant reductions to research spending and cut jobs as a result of the coronavirus pandemic.
Sources9 sources
- 1Cancer Research UK: Our historycancerresearchuk.org
- 2Cancer Research UK: Our peoplecancerresearchuk.org
- 3Cancer Research UK: Race for Lifecancerresearchuk.org
- 4Cancer Research UK: Stand Up To Cancercancerresearchuk.org
- 5Cancer Research UK calls for urgent action to protect cancer researchcancerresearchuk.org
- 6Cancer Research UK与ALBORADA Trust宣布奖学金合作civilsociety.co.uk
- 7Tesco与健康慈善机构合作推广流感疫苗接种thegrocer.co.uk
- 8Cancer Research UK 与 Teon 合作推进 TT-702 开发pharmatimes.com
- 9Cancer Research UK计划裁员bracknellnews.co.uk
Cite this profile: Cite the canonical profile. /brand-wiki/cancer-research-uk · Editorial policy · How profiles are compiled